Rats that infested a Philadelphia warehouse 40 years ago have found their way into the legal nightmares of the nation’s drug companies. Frustrated that even
Forest Laboratories settling antidepressant suits
A month after its Earth City subsidiary pleaded guilty of illegally marketing antidepressants to children and adolescents, Forest Laboratories is now settling a string of
Glaxo to Pay $750 Million for Sale of Bad Products
GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated
Hormone therapy raises breast cancer deaths: study
Women who took hormone replacement pills had more advanced breast cancers and were more likely to die from them than women who took a dummy
17,000 doctors cash in drug company money, report finds
More than 17,000 doctors and other health care providers have taken money from seven major drug companies to talk to other doctors about their products,
CareFusion recall classified as most serious type
The Food and Drug Administration has classified CareFusion Corp’s August recall of 17,000 Alaris medication pumps as a Class I recall, the most serious type,
FDA warns of thigh fractures with bone drugs
Osteoporosis drugs used by millions of women to prevent bones from breaking may increase the chances for an unusual type of thigh fracture, U.S. health
Pfizer depression drug ineffective, may be harmful: study
Pfizer’s antidepressant reboxetine is an “ineffective and potentially harmful” drug and published data on it overestimates the benefits and underplays the risks, a study by
Drug Side Effects May Include Lawsuits
For decades, antipsychotic drugs were a niche product. Today, they’re the top-selling class of pharmaceuticals in America, generating annual revenue of about $14.6 billion and
